COVID-19 Boosts Sanofi's Ageing Lovenox Franchise, But Holds Back Travel Vaccine Sales

Vaccines Near Late-Stage Studies

 
• By John Davis
  
Sanofi in Gentily, France
• Source: Alamy

More from Earnings

More from Business